Cargando…
Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2
Mesenchymal stem cells (MSCs), defined as plastic adherent cells with multipotent differentiation capacity in vitro, are an emerging and valuable tool to treat a plethora of diseases due to their therapeutic mechanisms such as their paracrine activity, mitochondrial and organelle transfer, and trans...
Autores principales: | Juárez-Navarro, Karen J., Padilla-Camberos, Eduardo, Díaz, Néstor Fabián, Miranda-Altamirano, Ariel, Díaz-Martínez, N. Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769649/ https://www.ncbi.nlm.nih.gov/pubmed/33414832 http://dx.doi.org/10.1155/2020/8892189 |
Ejemplares similares
-
Editing the Central Nervous System Through CRISPR/Cas9 Systems
por: Cota-Coronado, Agustin, et al.
Publicado: (2019) -
Biomolecules resveratrol + coenzyme Q10 recover the cell state of human mesenchymal stem cells after 1-methyl-4-phenylpyridinium-induced damage and improve proliferation and neural differentiation
por: Hernández-Pérez, Oscar R., et al.
Publicado: (2022) -
iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020) -
In vitro and In vivo Postprandial Glycemic Activity of Citrus limetta Peel Flour
por: Flores-Fernández, José Miguel, et al.
Publicado: (2017) -
Recent advances in the use of CRISPR/Cas for understanding the early development of molecular gaps in glial cells
por: Barragán-Álvarez, Carla Patricia, et al.
Publicado: (2022)